Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000090962

Apexbio Technology LLC GSK 2830371 1404456-53-6 10mg
SDP

Catalog No. 5000090962
Encompass_Preferred

GSK 2830371 (CAS 1404456-53-6) is a potent orally bioavailable small molecule that acts as an allosteric inhibitor of Wip1 phosphatase By selectively targeting Wip1 a serine/threonine phosphatase involved in the regulation of DNA damage response pathways GSK 2830371 disrupts downstream signaling events critical for cell cycle progression and genomic stability The compound exhibits an IC of 6 nM against Wip1 in biochemical assays reflecting high inhibitory potency GSK 2830371 is utilized in biomedical research to investigate Wip1 s role in oncogenic processes and to explore the therapeutic potential of Wip1 inhibition in cancer and related pathologies

Catalog No. 50-000-90962 Supplier Apexbio Technology LLC Supplier No. B116910
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK 2830371 (CAS 1404456-53-6) is a potent orally bioavailable small molecule that acts as an allosteric inhibitor of Wip1 phosphatase By selectively targeting Wip1 a serine/threonine phosphatase involved in the regulation of DNA damage response pathways GSK 2830371 disrupts downstream signaling events critical for cell cycle progression and genomic stability The compound exhibits an IC of 6 nM against Wip1 in biochemical assays reflecting high inhibitory potency GSK 2830371 is utilized in biomedical research to investigate Wip1 s role in oncogenic processes and to explore the therapeutic potential of Wip1 inhibition in cancer and related pathologies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.